9780792381471 - angiotensin ii receptor blockade physiological and clinical implications: 2 (progress in experimental cardiology, 2) (7 resultados)
Angiotensin II Receptor Blockade; Physiological and Clinical Implications
DHALLA, Naranjan S., Peter Zahradka, Ian M. C. Dixon, Robert E. Beamish (eds.)
- Tapa dura
- Primera edición
Librería: BISON BOOKS - ABAC/ILAB, Winnipeg, MB, CanadaBISON BOOKS - ABAC/ILAB
Contactar con el vendedorVendedor de 4 estrellasCondición: Usado
EUR 46,65
Envío por EUR 11,23Se envía de Canada a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. 1st edition. pp. xlii, 588. Heavy 8vo. Boards very sl. bowed; else near fine condition. A title in the Progress in Experimental Cardiology series. black-&-white illustrations (ilustrador).
Angiotensin II Receptor Blockade: (Progress in Experimental Cardiology)
Naranjan S. Dhalla, Peter Zahradka, Robert E. Beamish, Ian M.C. Dixon
- Tapa dura
Librería: Bookmans, tucson, AZ, Estados Unidos de AmericaBookmans
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Aceptable
EUR 145,25
Envío por EUR 3,45Se envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: Good. Satisfaction 100% guaranteed.
- Tapa dura
Librería: Ria Christie Collections, Uxbridge, Reino UnidoRia Christie Collections
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 313,39
Envío por EUR 13,98Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New. In.
Angiotensin II Receptor Blockade
. Ed(s): Dhalla, Naranjan S.; Zahradka, Peter; Dixon, Ian M. C. (St. Boniface General Hospital Research Centre); Beamish, R.E.
- Tapa dura
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 377,41
Envío por EUR 9,50Se envía de Irlanda a Estados Unidos de AmericaCantidad disponible: 15 disponibles
Condición: New. Focuses on the developments in the molecular biology, cellular physiology and structure-function relationships of angiotensin II and its receptors. This volume covers the therapeutic uses for angiotensin receptor antagonists and considers their potential applications. Editor(s): Dhalla, Naranjan S.; Zahradka, Pet…er; Dixon, Ian M. C. (St. Boniface General Hospital Research Centre); Beamish, R.E. Series: Progress in Experimental Cardiology. Num Pages: 588 pages, biography. BIC Classification: MJD. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 234 x 156 x 34. Weight in Grams: 1061. . 1998. Hardback. . . . .
Angiotensin II Receptor Blockade Physiological and Clinical Implications
Dhalla, Naranjan S.|Zahradka, Peter|Dixon, Ian M. C.|Beamish, Robert E.
- Tapa dura
Librería: moluna, Greven, Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 336,82
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Gebunden. Condición: New. The relationship between angiotensin II and hypertension was established in 1898 when angiotensin II was shown to modulate systemic blood pressure. Over the intervening decades, a complete characterization of the renin-angiotensin system (RAS) has been achi.
Angiotensin II Receptor Blockade
. Ed(s): Dhalla, Naranjan S.; Zahradka, Peter; Dixon, Ian M. C. (St. Boniface General Hospital Research Centre); Beamish, R.E.
- Tapa dura
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de AmericaKennys Bookstore
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 474,36
Envío por EUR 9,08Se envía dentro de Estados Unidos de AmericaCantidad disponible: 15 disponibles
Condición: New. Focuses on the developments in the molecular biology, cellular physiology and structure-function relationships of angiotensin II and its receptors. This volume covers the therapeutic uses for angiotensin receptor antagonists and considers their potential applications. Editor(s): Dhalla, Naranjan S.; Zahradka, Pet…er; Dixon, Ian M. C. (St. Boniface General Hospital Research Centre); Beamish, R.E. Series: Progress in Experimental Cardiology. Num Pages: 588 pages, biography. BIC Classification: MJD. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 234 x 156 x 34. Weight in Grams: 1061. . 1998. Hardback. . . . . Books ship from the US and Ireland.
- Tapa dura
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 474,63
Envío por EUR 65,55Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Buch. Condición: Neu. Neuware - The relationship between angiotensin II and hypertension was established in 1898 when angiotensin II was shown to modulate systemic blood pressure. Over the intervening decades, a complete characterization of the renin-angiotensin system (RAS) has been achieved, and our understanding of its bioche…mistry and physiology has led to the directed development of agents such as ACE inhibitors and receptor antagonists capable of controlling hypertension. More recently, it was shown that angiotensin II is secreted within certain tissues and that these tissue-specific systems operate independently of the systemic RAS. The novel concept that angiotensin II regulates a number of cardiovascular processes that are unrelated to blood pressure has renewed the interest of both basic and clinical scientists in angiotensin II. The association between angiotensin II and cardiac growth, in particular, has indicated that therapies currently in use for hypertension may have direct application to the treatment of heart failure. The Manitoba Cardiovascular Forum on Angiotensin Receptor Blockade in Winnipeg was convened October 18-20, 1996 to examine the clinical and basic aspects of angiotensin receptor biology as they apply to hypertension and heart failure. In addition, the potential treatment of these conditions using specific angio tensin receptor antagonists was addressed within the context of their immediate therapeutic application and future potential.
